2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gynecologic
2
Other
1
Conditions
Endometrial Neoplasms
2
Overweight
1
Obesity
1
Metabolic Disturbance
1
Interventions
Cyclophosphamide
3155
Cisplatin
3151
Carboplatin
2929
Paclitaxel
2671
Radiotherapy
2643
Gemcitabine
2544
pembrolizumab
2324
Docetaxel
2154
Bevacizumab
2126
Fluorouracil
1819
Capecitabine
1780
Oxaliplatin
1709
Dexamethasone
1589
Nivolumab
1516
Doxorubicin
1477
Rituximab
1453
Etoposide
1341
Magnetic Resonance Spectroscopy
1261
Irinotecan
1232
Leucovorin
1212
Cytarabine
1123
Pemetrexed
1060
Drug Therapy
1060
fludarabine
1044
Vincristine
956
Specimen Handling
928
Prednisone
924
Cetuximab
919
Lenalidomide
916
Trastuzumab
897
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Interventional
×
Trehalase
×
Clear all
NCT06855784
2026-01-27
TREMHO
University Hospital, Geneva
Phase NA
Recruiting
84 enrolled
NCT05454943
2025-10-01
READY
University of Toronto
Phase NA
Completed
178 enrolled
NCT04763902
2023-11-30
TIMESPAN
University of Utah
Phase NA
Completed
17 enrolled
NCT04783467
2023-11-30
TREND
University of Utah
Phase NA
Unknown
15 enrolled